DEURUXOLITINIB PHOSPHATE

174 reported adverse events

These side effects are most commonly reported by patients taking DEURUXOLITINIB PHOSPHATE:

# Side effect Count
0 PRODUCT USE ISSUE 39
1 DRUG INEFFECTIVE 28
2 PRODUCT DOSE OMISSION ISSUE 20
3 THERAPY CESSATION 15
4 FATIGUE 11
5 ACNE 10
6 HEADACHE 7
7 CONDITION AGGRAVATED 6
8 INTENTIONAL DOSE OMISSION 6
9 NASOPHARYNGITIS 6
See all common reactions for DEURUXOLITINIB PHOSPHATE

DEURUXOLITINIB PHOSPHATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IMPETIGO 1 0.0007
1 INFECTIOUS MONONUCLEOSIS 1 0.0004
2 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
3 THERAPY CESSATION 15 0.0003
4 SUICIDAL BEHAVIOUR 1 0.0002
5 PRODUCT DISPENSING ISSUE 1 0.0002
6 INTENTIONAL DOSE OMISSION 6 0.0002
7 PRODUCT USE ISSUE 39 0.0002
8 STREPTOCOCCAL INFECTION 1 0.0002
9 HERPES VIRUS INFECTION 1 0.0002
See all enriched reactions for DEURUXOLITINIB PHOSPHATE